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Comparison of the phosphotyrosine-specific dephosphorylation of the autophosphorylated receptors for epidermal growth factor (EGF) and 
platelet-derived growth factor (PDGF) in Swiss 3T3 cell membranes by the endogenous phosphatases revealed striking differences. EGF receptor 
dephosphorylation was clearly faster than PDGF receptor dephosphorylation and strongly inhibited by Triton X-100 and octylglucoside, whereas 
PDGF receptor dephosphorylation was to a lesser extent detergent-susceptible. PDGF receptor dephosphorylation was effectively inhibited by 
phenylarsineoxide, protamine and poly-lysine and partially by N-ethylmaleinimide, whereas EGF receptor dephosphorylation was not affected by 
these agents. We suggest hat these differences in dephosphorylation of EGF and PDGF receptors are due to their differential interaction with 
membrane-associated protein-tyrosine phosphatases and important for differential regulation of receptor signalling. 
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1. INTRODUCTION 
The autophosphorylation of growth factor receptor 
tyrosine kinases generates binding sites for Src-homol- 
ogy 2 (SH2) domains of downstream signalling mole- 
cules and is therefore crucial for tyrosine kinase recep- 
tor signalling (for review see [ 11). It is likely that regula- 
tion of receptor tyrosine phosphorylation by 
dephosphorylation of the autophosphorylated recep- 
tors is important for the regulation of tyrosine kinase 
receptor signalling. Much attention has recently been 
focused on the identification and characterisation of 
protein phosphotyrosine phosphatases (for review see 
[2]). Various PTPases have been shown to dephosphor- 
ylate purified autophosphorylated growth factor recep- 
tors in vitro [3-51. Alternatively, the possible function 
of certain PTPases in the regulation of growth factor 
receptor activity has been studied by transfection of 
cells with PTPase genes [6,7] and subsequent analysis of 
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receptor function. It is not known which PTPase species 
physiologically interact with the various tyrosine kinase 
receptors and to what extent the receptor-directed 
dephosphorylation might be specific. We, therefore, in- 
vestigated the dephosphorylation of two growth factor 
receptors in situ in their physiological environment, i.e. 
the plasma membrane of non-transfected cells. Various 
parameters of the dephosphorylation of both receptors 
by the endogenous PTPases were found to be clearly 
different, pointing to a differential regulation of the 
different tyrosine kinase receptors by dephosphoryla- 
tion in the same cell. 
2. MATERIALS AND METHODS 
2.1. Materials 
A peptide-specific antiserum (15E) against the EGF receptor was 
generously provided by W.J. Gullick (London). Antiserum DIG1 was 
raised against a peptide corresponding to amino acid residues 1,075- 
1,089 in the human PDGF u-receptor but recognised PDGF a- and 
B-receptor equally well (L.J. Gonez, unpublished ata). For receptor 
detection in immunoblots, the antibodies were used in the following 
concentrations: Anti-PDGF receptor antiserum DIGl, 111000; anti- 
EGF receptor antiserum 15E, l/50. 
2.2. Cells and membrane preparation 
Swiss 3T3 cells were cultured in Dulbecco’s modified Eagle medium 
(Gibco/Bethesda Research Laboratories, Gaithersburg, MD) supple- 
mented with 10% foetal calf serum, glutamine (2 mM), penicillin (100 
IU/ml) and streptomycin (100 III/ml). Membranes were prepared 
from confluent roller cultures according to the method of Thorn et al. 
181. 
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2.3. Measurement of receptor autophosphorylation and dephosphoryla- 
tion 
For measurement of receptor autophosphorylation and dephos- 
phorylation, membranes (10 pug protein per assay) were incubated in 
the presence of 1.2 &ml EGF or 2&ml PDGF, 50 mM HEPES (PH 
7.5) and 3 mM MnCl, (tinal concentrations) in a volume of 40 ~1 for 
20 min on ice. In order to test the effects of various compounds on 
the autophosphorylation, these were added in a volume of 5 ,!d 10 min 
after addition of the growth factor. Phosphorylation was initiated by 
addition of [$*P]ATP (3-5 @i, final concentration 2.uM) and termi- 
nated after 2 min by addition of 10 ~1 of dfold concentrated SDS 
PAGE sample buffer. The samples were subjected SDS-PAGE accord- 
ing to the method of Blobel and Dobberstein [9] using 10% acrylamide 
gels and subjected to autoradiographic analysis. To monitor 
dephosphorylation, the phosphorylation reaction was quenched after 
2 min by addition of unlabelled ATP @H 7.5, 1 mM final concentra- 
tion) or EDTA (pH 7.5, 10 mM Iinal concentration). In some experi- 
ments the phosphorylation was quenched by addition of hexokinase 
(Boehringer, Mannheim, 0.2 U/assay) and n-glucose (1 mM, tinal 
concentration). After quenching of the phosphorylation reaction, the 
tubes were shifted to the desired temperature, dephosphorylation was 
allowed for the indicated time and then abrogated by addition of 
concentrated SDS-PAGE sample buffer (see above). Standard condi- 
tions for effector tests were dephosphorylation for 5 min and 30 min 
at 15’C for EGF receptor and PDGF receptor, respectively. Vanadate 
stock solutions were prepared as described [lo]. For measuring pH- 
dependence of the dephosphorylation, phosphorylation was per- 
formed in a volume of 25 ~1 with 20 mM HEPES @H 7.5) as the buffer. 
Then, unlabelled ATP was added in another 25 ~1 of 0.3 M HEPES 
@H 6.5-8.5) or 0.3 M MES (PH 5.5 and 6.0) and the dephosphoryla- 
tion was monitored. 
2.4. Phosphoamino acid analysis 
Phosphoamino acid analysis was performed after immunoblotting 
as described by Kamps and Sefton [l 11. 
2.5. QuantiJication of autoradiograms 
For quantification of radioactivity in electrophoresis gels or thin 
layer plates, a Phosphorbnager (Molecular Dynamics, Sunnyvale, 
CA) with the program ImageQuant was used according to the instruc- 
tions of the manufacturer. To obtain autoradiograms, objects were 
exposed to X-ray f&n (Fuji RX) with intensifying screen (DuPont 
Cronex Lightning Plus) at -70°C. 
3. RESULTS 
3.1. Receptor dephosphorylation kinetics 
The receptors for EGF and PDGF in membranes 
isolated from Swiss 3T3 cells were activated with satu- 
rating concentrations of growth factors and auto- 
phosphorylation was allowed in the presence of [r- 
32P]ATP (Fig. 1, inset). Radioactive electrophoretic 
bands corresponding to the respective auto- 
phosphorylated receptors were identified by ligand- 
stimulated incorporation of radioactivity, molecular 
mass and immunoblotting with receptor-specific anti- 
bodies. The extent of receptor phosphorylation was 
quantified by autoradiographic analysis with the help of 
a PhosphorImager. Phosphoamino acid analysis re- 
vealed that the autophosphorylated EGF and PDGF 
receptors contained 92 and 89% phosphotyrosine and 
8 and 11% phosphoserine, respectively; phosphothreon- 
ine was below the detection limit. 
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Fig. 1. Tie-course of receptor dephosphorylation. Membranes (10 
pg protein) isolated from confluent Swiss 3T3 cells were incubated 
with saturating amounts of growth factors as indicated and 
phosphorylated with [r-‘*P]ATP. The phosphorylation was quenched 
by addition of unlabelled ATP and the dephosphorylation was moni- 
tored at the indicated temperatures. At the respective time-points the 
reaction was abrogated by addition of SDS-PAGE sample buffer. The 
samples were subjected to SDS-PAGE and the relative radioactivity 
in the receptor bands was quantitated with a PhosphorImager. Inset: 
receptor autophosphorylation at start of dephosphorylation experi- 
ment (overnight autoradiography). 
the kinase reaction was quenched with unlabelled ATP 
and dephosphorylation monitored at different tempera- 
tures are depicted for both receptors in Fig. 1. To ensure 
that the decrease in radioactivity was not caused by 
receptor degradation, membrane samples were analysed 
by immunoblotting for the presence of the receptor pro- 
tein at different time-points during a dephosphorylation 
experiment at 25°C and the receptor contents were 
found to be essentially unchanged. Phosphoamino acid 
analysis performed at different time-points of receptor 
dephosphorylation at 25°C revealed that the decay in 
phosphotyrosine content in the receptors closely 
matched the decay in total radioactivity, whereas the 
content in phosphoserine stayed unchanged. The 
dephosphorylation affected multiple phosphorylation 
sites, as judged by monitoring receptor dephosphoryla- 
tion at the level of tryptic phosphopeptide maps (not 
shown). 
The dephosphorylation was clearly temperature-de- 
pendent, i.e. accelerated at higher temperature. When 
compared at the same temperature, EGF receptors were 
significantly more rapidly dephosphorylated than 
PDGF receptors. A clearly faster dephosphorylation of 
EGF receptors as compared with PDGF receptors was 
also observed when the phosphorylation reaction was 
quenched with either EDTA or by depletion of radioac- 
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tive ATP with the help of an efficient ATP-consuming 
reaction (not shown). Depending on the assay condi- 
tions, the difference in the initial dephosphorylation 
rate of both receptors was 2-lo-fold. 
3.2. pH-Dependence 
The pH-dependence of receptor dephosphorylation 
revealed optimal dephosphorylation for both receptors 
between pH 6 and 6.5 with relatively little change in the 
activity between pH 5.5 and 7. Between pH 7 and 8, the 
dephosphorylating activity decreased significantly. 
3.3. Effector studies 
Various known effecters of PTPases were examined 
for their effects on the dephosphorylation of EGF and 
PDGF receptors (Table I). The widely used PTPase 
inhibitor orthovanadate only partially inhibited the 
dephosphorylation of both EGF receptors as well as 
PDGF receptors. In contrast, zinc acetate was an effec- 
tive blocker of the dephosphorylation of both receptors. 
N-ethyhnaleinimide and phenylarsineoxide partially in- 
hibited PDGF receptor dephosphorylation but had lit- 
tle effect on EGF receptor dephosphorylation. P-hy- 
droxymercurybenzoic acid, however, blocked PDGF 
receptor dephosphorylation completely and EGF re- 
ceptor dephosphorylation also to a large extent. Dithio- 
threitol activated the dephosphorylation of both recep- 
tors. Poly-lysine and protamine at 25 @ml inhibited 
strongly the PDGF receptor dephosphorylation. Both 
had almost no effect on the EGF receptor 
dephosphorylation. Conversely, Triton X-100 and 
octylglucoside were revealed to be more potent inhib- 
itors of EGF receptor dephosphorylation when directly 
compared with PDGF receptor dephosphorylation. 
For comparison, some of the inhibitors of receptor 
dephosphorylation were tested for their effects on the 
receptor autophosphorylation (Table I). Overall, the ef- 
fects of the agents on kinase activities of the receptors 
did not correlate with their effects on receptor 
dephosphorylation. For example, vanadate and Triton 
X-100 had stimulating effects on the phosphorylation 
but inhibited dephosphorylation; N-ethyhnaleinimide 
potently inhibited the kinase reactions but had only 
partial effects on PDGF receptor dephosphorylation 
and no effect on EGF receptor dephosphorylation. 
4. DISCUSSION 
We suggest hat some of the observed characteristics 
of the dephosphorylation of PDGF and EGF receptors 
Table I 
Effect of various compounds on receptor dephosphorylation and receptor autophosphorylation i Swiss 3T3 cell membranes 
Compound Concentration Relative dephosphorylation 
(% of control) 
EGFR PDGFR 
Relative autophosphorylation 
(% of control) 
EGFR PDGFR 
Vanadate 0.01 mM 84 61 
0.1 mM 16 69 
1 mM 67 76 107 111 
Zn-acetate 0.01 mM 80 84 
0.1 mM 16 21 
1 mM 0 6 0 0 
Phenylarsine oxide 0.1 mM 99 65 70 64 
1 mM 1.5 39 40 21 
4 mM 64 17 9 5 
Iodoacetic acid 1 mM 105 104 
Iodoacetamide 1 mM 101 87 
N-ethyhnaleinimide 1 mM 96 73 14 21 
5 mM 92 66 
Dithiothreitol 1 mM 120 151 
5 mM 132 176 
PHMB 1 mM 39 0 
Spermidine 2 mM 106 106 
Spermine 2 mM 99 78 
CaCl, 2 mM 104 98 
MgCl, 2 mM 107 99 
Heparin 25 &ml 100 105 
Protamine 25 &ml 83 19 99 49 
Poly-lysine 25 ,ug/ml 95 46 135 60 
SDS 1% 0 0 
Triton X-100 1% 49 14 165 122 
Gctylglucoside 1% 46 70 
Membrane samples were treated with the respective growth factors and the extent of receptor dephosphorylation or receptor autophosphorylation 
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Fig. 2. pH-dependence of receptor dephosphorylation. EGF or PDGF 
receptors in Swiss 3T3 cell membranes (as indicated) were auto- 
phosphorylated at pH 7.5 on ice. Then, the phosphorylation was 
quenched by addition of unlabelled ATP. Concomitantly, the pH was 
shifted to the desired value. The figures express the relative extent of 
dephosphorylation compared to not dephosphorylated samples (0%). 
might partially explain previously known characteris- 
tics of receptor signalling. So, the relative resistance of 
PDGF receptors to dephosphorylation could contribute 
to the more sustained mitogenic effect of PDGF com- 
pared to EGF in Swiss 3T3 cells [12]. Relatively small 
differences in intracellular pH in the range 7-8 were 
found to have large effects on the receptor 
dephosphorylation. Intracellular pH-changes in this 
range might therefore affect receptor signalling activity. 
For example, the higher intracellular pH observed in 
growth factor-stimulated cells [ 131 could support mito- 
genie signalling by reducing receptor dephosphoryla- 
tion activity. 
In the effector studies, a differential sensitivity of 
phosphorylating and dephosphorylating activities to 
various inhibitors was observed. This finding strongly 
suggests that the observed dephosphorylating activities 
cannot be intrinsic to the receptors themselves. In keep- 
ing with this conclusion, receptor purification by im- 
munoprecipitation or several chromatographic steps re- 
moved most of the receptor dephosphorylating activity 
(not shown). The possibility that the known reversibility 
of receptor autophosphorylation [14] contributes to the 
measured ecay of radioactivity in the receptors is like- 
wise excluded by these data, in agreement with largely 
identical results obtained by comparing different meth- 
ods of quenching of the kinase reaction. 
The knowledge of effector susceptibility of receptor 
dephosphorylation might help to identify the involved 
elusive PTPases. The relatively low sensitivity of 
dephosphorylation of both receptors to vanadate versus 
a high sensitivity to zinc acetate matches previously 
described inhibitor characteristics of transmembrane- 
PTPases better than those cytosolic PTPases [4,15,16]. 
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We further observed a differential sensitivity to inhib- 
itors of dephosphorylation of the two different recep- 
tors. One obvious explanation for this finding would be 
the involvement of different PTPases with distinct sus- 
ceptibilities in the both processes. Alternatively, the 
lower sensitivity of EGF receptor dephosphorylation to 
polycations, phenylarsine oxide and some general 
sulfbydryl-blocking reagents might reflect a sterical hin- 
drance for these reagents to reach the active site of the 
EGF receptor dephosphorylating PTPase(s). Such a 
sterical hindrance could be the result of the existence of 
a tight complex between receptor and PTPase(s) which 
would prevent access of the reagents. The latter inter- 
pretation might explain also the high efficiency of EGF 
receptor dephosphorylation and in particular, the high 
susceptibility of EGF receptor dephosphorylation to 
inhibition of the two receptors is indicated by the results 
of the inhibition studies. 
Previous attempts to identify growth factor receptor 
PTPases biochemically might have been hampered by 
the drastic inhibition of receptor dephosphorylation in 
the presence of detergents, as described in this paper 
and likewise observed in case of insulin and EGF recep- 
tors in rat liver endosomal membranes [17]. Since a 
denaturing effect of the employed detergents on the 
involved PTPases is rather unlikely, the detergent sus- 
ceptibility suggests that the receptor-PTPase interaction 
is relatively labile and depends on the membrane lipid 
environment. Thus, future approaches to identify recep- 
tor-directed PTPases should aim at stabilising a puta- 
tive growth factor receptor-PTPase complex. 
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